25
Participants
Start Date
December 16, 2008
Primary Completion Date
September 29, 2009
Study Completion Date
September 29, 2009
ARRY-371797, p38 inhibitor; oral
multiple dose, single schedule
Placebo; oral
matching placebo
Placebo; oral
multiple dose, single schedule
Low Country Rheumatology, Charleston
Northwestern University, Chicago
Westroads Medical Group, Omaha
Lynn Health Science Institute, Oklahoma City
Cedars-Sinai Medical Center, Los Angeles
Oregon Health & Science University, Portland
Arthritis Northwest, Spokane
Rheumatology Research Associates Group, Edmonton
University of Manitoba, Winnipeg
Credit Valley Rheumatology, Mississauga
Center de Recherche Musculo-Squelettique, Trois-Rivières
University of Saskatchewan, Saskatoon
Lead Sponsor
Pfizer
INDUSTRY